Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 9 |
GO:0110165 | cellular anatomical entity | 1 | 9 |
Related structures:
AlphaFold database: E9AYQ5
Term | Name | Level | Count |
---|---|---|---|
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 12 |
GO:0006396 | RNA processing | 6 | 12 |
GO:0006399 | tRNA metabolic process | 7 | 12 |
GO:0006400 | tRNA modification | 6 | 12 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 12 |
GO:0006807 | nitrogen compound metabolic process | 2 | 12 |
GO:0008033 | tRNA processing | 8 | 12 |
GO:0008152 | metabolic process | 1 | 12 |
GO:0009451 | RNA modification | 5 | 12 |
GO:0009987 | cellular process | 1 | 12 |
GO:0016070 | RNA metabolic process | 5 | 12 |
GO:0034470 | ncRNA processing | 7 | 12 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 12 |
GO:0034660 | ncRNA metabolic process | 6 | 12 |
GO:0043170 | macromolecule metabolic process | 3 | 12 |
GO:0043412 | macromolecule modification | 4 | 12 |
GO:0044237 | cellular metabolic process | 2 | 12 |
GO:0044238 | primary metabolic process | 2 | 12 |
GO:0046483 | heterocycle metabolic process | 3 | 12 |
GO:0071704 | organic substance metabolic process | 2 | 12 |
GO:0090304 | nucleic acid metabolic process | 4 | 12 |
GO:0101030 | tRNA-guanine transglycosylation | 7 | 12 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 12 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 12 |
GO:0005488 | binding | 1 | 9 |
GO:0008479 | queuine tRNA-ribosyltransferase activity | 5 | 9 |
GO:0016740 | transferase activity | 2 | 12 |
GO:0016757 | glycosyltransferase activity | 3 | 12 |
GO:0016763 | pentosyltransferase activity | 4 | 12 |
GO:0043167 | ion binding | 2 | 9 |
GO:0043169 | cation binding | 3 | 9 |
GO:0046872 | metal ion binding | 4 | 9 |
GO:0140098 | catalytic activity, acting on RNA | 3 | 9 |
GO:0140101 | catalytic activity, acting on a tRNA | 4 | 9 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 2 | 9 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 256 | 260 | PF00656 | 0.540 |
CLV_MEL_PAP_1 | 327 | 333 | PF00089 | 0.248 |
CLV_NRD_NRD_1 | 135 | 137 | PF00675 | 0.255 |
CLV_PCSK_KEX2_1 | 13 | 15 | PF00082 | 0.254 |
CLV_PCSK_KEX2_1 | 133 | 135 | PF00082 | 0.255 |
CLV_PCSK_KEX2_1 | 279 | 281 | PF00082 | 0.295 |
CLV_PCSK_PC1ET2_1 | 13 | 15 | PF00082 | 0.315 |
CLV_PCSK_PC1ET2_1 | 133 | 135 | PF00082 | 0.255 |
CLV_PCSK_PC1ET2_1 | 279 | 281 | PF00082 | 0.297 |
CLV_PCSK_SKI1_1 | 136 | 140 | PF00082 | 0.290 |
CLV_PCSK_SKI1_1 | 324 | 328 | PF00082 | 0.423 |
CLV_PCSK_SKI1_1 | 67 | 71 | PF00082 | 0.279 |
DEG_APCC_DBOX_1 | 282 | 290 | PF00400 | 0.528 |
DEG_Nend_UBRbox_2 | 1 | 3 | PF02207 | 0.617 |
DOC_MAPK_gen_1 | 198 | 204 | PF00069 | 0.559 |
DOC_MAPK_gen_1 | 96 | 103 | PF00069 | 0.497 |
DOC_MAPK_MEF2A_6 | 114 | 121 | PF00069 | 0.495 |
DOC_MAPK_MEF2A_6 | 233 | 241 | PF00069 | 0.515 |
DOC_PP2B_LxvP_1 | 237 | 240 | PF13499 | 0.540 |
DOC_PP2B_LxvP_1 | 8 | 11 | PF13499 | 0.465 |
DOC_PP4_FxxP_1 | 46 | 49 | PF00568 | 0.515 |
DOC_USP7_MATH_1 | 214 | 218 | PF00917 | 0.556 |
DOC_USP7_MATH_1 | 326 | 330 | PF00917 | 0.507 |
DOC_USP7_MATH_1 | 81 | 85 | PF00917 | 0.519 |
DOC_USP7_MATH_1 | 99 | 103 | PF00917 | 0.367 |
DOC_WW_Pin1_4 | 18 | 23 | PF00397 | 0.456 |
DOC_WW_Pin1_4 | 193 | 198 | PF00397 | 0.551 |
LIG_14-3-3_CanoR_1 | 135 | 145 | PF00244 | 0.477 |
LIG_14-3-3_CanoR_1 | 317 | 322 | PF00244 | 0.441 |
LIG_14-3-3_CanoR_1 | 34 | 44 | PF00244 | 0.454 |
LIG_14-3-3_CanoR_1 | 73 | 77 | PF00244 | 0.506 |
LIG_14-3-3_CanoR_1 | 98 | 104 | PF00244 | 0.464 |
LIG_BIR_III_2 | 175 | 179 | PF00653 | 0.540 |
LIG_BIR_III_4 | 2 | 6 | PF00653 | 0.540 |
LIG_BRCT_BRCA1_1 | 182 | 186 | PF00533 | 0.564 |
LIG_Clathr_ClatBox_1 | 238 | 242 | PF01394 | 0.500 |
LIG_FHA_1 | 199 | 205 | PF00498 | 0.492 |
LIG_FHA_2 | 138 | 144 | PF00498 | 0.487 |
LIG_FHA_2 | 227 | 233 | PF00498 | 0.472 |
LIG_FHA_2 | 244 | 250 | PF00498 | 0.514 |
LIG_FHA_2 | 289 | 295 | PF00498 | 0.465 |
LIG_LIR_Apic_2 | 45 | 49 | PF02991 | 0.497 |
LIG_LIR_Gen_1 | 181 | 192 | PF02991 | 0.517 |
LIG_LIR_Gen_1 | 38 | 49 | PF02991 | 0.516 |
LIG_LIR_Nem_3 | 104 | 109 | PF02991 | 0.495 |
LIG_LIR_Nem_3 | 181 | 187 | PF02991 | 0.528 |
LIG_LIR_Nem_3 | 58 | 63 | PF02991 | 0.454 |
LIG_LIR_Nem_3 | 64 | 69 | PF02991 | 0.457 |
LIG_LIR_Nem_3 | 74 | 79 | PF02991 | 0.488 |
LIG_MYND_1 | 18 | 22 | PF01753 | 0.465 |
LIG_NRBOX | 285 | 291 | PF00104 | 0.528 |
LIG_PDZ_Class_1 | 330 | 335 | PF00595 | 0.523 |
LIG_SH2_CRK | 60 | 64 | PF00017 | 0.552 |
LIG_SH2_CRK | 66 | 70 | PF00017 | 0.527 |
LIG_SH2_SRC | 173 | 176 | PF00017 | 0.559 |
LIG_SH2_SRC | 285 | 288 | PF00017 | 0.454 |
LIG_SH2_STAT5 | 173 | 176 | PF00017 | 0.492 |
LIG_SH2_STAT5 | 285 | 288 | PF00017 | 0.476 |
LIG_SH2_STAT5 | 60 | 63 | PF00017 | 0.552 |
LIG_SUMO_SIM_anti_2 | 217 | 223 | PF11976 | 0.522 |
LIG_SUMO_SIM_anti_2 | 297 | 304 | PF11976 | 0.468 |
LIG_SUMO_SIM_par_1 | 253 | 259 | PF11976 | 0.535 |
LIG_SUMO_SIM_par_1 | 288 | 294 | PF11976 | 0.454 |
LIG_SUMO_SIM_par_1 | 68 | 75 | PF11976 | 0.455 |
LIG_TRAF2_1 | 240 | 243 | PF00917 | 0.500 |
LIG_TRAF2_1 | 291 | 294 | PF00917 | 0.454 |
LIG_WRC_WIRS_1 | 100 | 105 | PF05994 | 0.559 |
MOD_CDC14_SPxK_1 | 196 | 199 | PF00782 | 0.559 |
MOD_CDK_SPK_2 | 193 | 198 | PF00069 | 0.559 |
MOD_CDK_SPxK_1 | 193 | 199 | PF00069 | 0.559 |
MOD_CK1_1 | 217 | 223 | PF00069 | 0.531 |
MOD_CK1_1 | 320 | 326 | PF00069 | 0.499 |
MOD_CK1_1 | 82 | 88 | PF00069 | 0.528 |
MOD_CK2_1 | 137 | 143 | PF00069 | 0.498 |
MOD_CK2_1 | 217 | 223 | PF00069 | 0.492 |
MOD_CK2_1 | 226 | 232 | PF00069 | 0.479 |
MOD_CK2_1 | 243 | 249 | PF00069 | 0.520 |
MOD_CK2_1 | 288 | 294 | PF00069 | 0.454 |
MOD_CK2_1 | 36 | 42 | PF00069 | 0.559 |
MOD_GlcNHglycan | 163 | 166 | PF01048 | 0.333 |
MOD_GlcNHglycan | 208 | 211 | PF01048 | 0.253 |
MOD_GlcNHglycan | 319 | 322 | PF01048 | 0.417 |
MOD_GlcNHglycan | 332 | 335 | PF01048 | 0.471 |
MOD_GlcNHglycan | 63 | 66 | PF01048 | 0.348 |
MOD_GlcNHglycan | 81 | 84 | PF01048 | 0.273 |
MOD_GSK3_1 | 137 | 144 | PF00069 | 0.521 |
MOD_GSK3_1 | 146 | 153 | PF00069 | 0.472 |
MOD_GSK3_1 | 155 | 162 | PF00069 | 0.439 |
MOD_GSK3_1 | 243 | 250 | PF00069 | 0.422 |
MOD_GSK3_1 | 326 | 333 | PF00069 | 0.537 |
MOD_GSK3_1 | 61 | 68 | PF00069 | 0.511 |
MOD_GSK3_1 | 79 | 86 | PF00069 | 0.462 |
MOD_N-GLC_1 | 217 | 222 | PF02516 | 0.340 |
MOD_NEK2_1 | 155 | 160 | PF00069 | 0.543 |
MOD_NEK2_1 | 186 | 191 | PF00069 | 0.564 |
MOD_NEK2_1 | 241 | 246 | PF00069 | 0.436 |
MOD_NEK2_1 | 36 | 41 | PF00069 | 0.515 |
MOD_NEK2_1 | 72 | 77 | PF00069 | 0.483 |
MOD_NEK2_1 | 79 | 84 | PF00069 | 0.445 |
MOD_OFUCOSY | 273 | 278 | PF10250 | 0.254 |
MOD_PKA_1 | 198 | 204 | PF00069 | 0.559 |
MOD_PKA_2 | 72 | 78 | PF00069 | 0.540 |
MOD_PKB_1 | 134 | 142 | PF00069 | 0.485 |
MOD_Plk_1 | 180 | 186 | PF00069 | 0.463 |
MOD_Plk_1 | 217 | 223 | PF00069 | 0.540 |
MOD_Plk_1 | 86 | 92 | PF00069 | 0.523 |
MOD_Plk_4 | 141 | 147 | PF00069 | 0.569 |
MOD_Plk_4 | 155 | 161 | PF00069 | 0.524 |
MOD_Plk_4 | 217 | 223 | PF00069 | 0.476 |
MOD_Plk_4 | 247 | 253 | PF00069 | 0.353 |
MOD_Plk_4 | 36 | 42 | PF00069 | 0.454 |
MOD_Plk_4 | 65 | 71 | PF00069 | 0.471 |
MOD_ProDKin_1 | 18 | 24 | PF00069 | 0.456 |
MOD_ProDKin_1 | 193 | 199 | PF00069 | 0.551 |
MOD_SUMO_for_1 | 147 | 150 | PF00179 | 0.528 |
TRG_DiLeu_BaEn_2 | 41 | 47 | PF01217 | 0.559 |
TRG_DiLeu_BaEn_4 | 150 | 156 | PF01217 | 0.559 |
TRG_DiLeu_BaLyEn_6 | 250 | 255 | PF01217 | 0.540 |
TRG_ENDOCYTIC_2 | 184 | 187 | PF00928 | 0.523 |
TRG_ENDOCYTIC_2 | 60 | 63 | PF00928 | 0.554 |
TRG_ENDOCYTIC_2 | 66 | 69 | PF00928 | 0.519 |
TRG_ER_diArg_1 | 134 | 136 | PF00400 | 0.479 |
TRG_NLS_MonoCore_2 | 132 | 137 | PF00514 | 0.455 |
TRG_NLS_MonoExtN_4 | 130 | 137 | PF00514 | 0.495 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1HWE8 | Leptomonas seymouri | 67% | 100% |
A0A0S4IR14 | Bodo saltans | 37% | 96% |
A0A1X0NPI6 | Trypanosomatidae | 40% | 100% |
A0A3R7K861 | Trypanosoma rangeli | 40% | 100% |
A0A3S7X0A8 | Leishmania donovani | 93% | 100% |
A4HFC2 | Leishmania braziliensis | 84% | 100% |
A4I2J9 | Leishmania infantum | 94% | 100% |
A5D3G6 | Pelotomaculum thermopropionicum (strain DSM 13744 / JCM 10971 / SI) | 25% | 91% |
B0WAN0 | Culex quinquefasciatus | 23% | 78% |
B2USB2 | Helicobacter pylori (strain Shi470) | 28% | 90% |
B3NCH1 | Drosophila erecta | 23% | 80% |
B3RNT0 | Trichoplax adhaerens | 23% | 91% |
B4H1X9 | Drosophila persimilis | 25% | 80% |
B4HL48 | Drosophila sechellia | 24% | 80% |
B4IXD3 | Drosophila grimshawi | 23% | 80% |
B4KXI8 | Drosophila mojavensis | 23% | 81% |
B4LFW2 | Drosophila virilis | 23% | 80% |
B4N549 | Drosophila willistoni | 23% | 78% |
B4PEV9 | Drosophila yakuba | 23% | 80% |
B5ZA47 | Helicobacter pylori (strain G27) | 27% | 90% |
B6JKL0 | Helicobacter pylori (strain P12) | 28% | 90% |
C9ZPM4 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 42% | 100% |
E9ACY0 | Leishmania major | 93% | 100% |
O08314 | Helicobacter pylori (strain ATCC 700392 / 26695) | 28% | 90% |
Q16RF5 | Aedes aegypti | 22% | 80% |
Q17YB5 | Helicobacter acinonychis (strain Sheeba) | 28% | 90% |
Q1CUM2 | Helicobacter pylori (strain HPAG1) | 28% | 90% |
Q29EE9 | Drosophila pseudoobscura pseudoobscura | 26% | 80% |
Q5SLI7 | Thermus thermophilus (strain ATCC 27634 / DSM 579 / HB8) | 27% | 87% |
Q7Q727 | Anopheles gambiae | 23% | 78% |
Q8YVT9 | Nostoc sp. (strain PCC 7120 / SAG 25.82 / UTEX 2576) | 23% | 90% |
Q9VSZ6 | Drosophila melanogaster | 24% | 80% |
Q9ZMF4 | Helicobacter pylori (strain J99 / ATCC 700824) | 28% | 90% |
V5BCL2 | Trypanosoma cruzi | 40% | 100% |